The Kanabo share price is down almost 40% since listing. Here’s what I’d do now

A huge drop in the Kanabo share price can either be an opportunity to buy or a signal to avoid the stock. Which one is it?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

With regulation of the cannabis sector increasingly being relaxed around the world, including in the UK, companies in the segment may be poised for great growth. Israel-based Kanabo Group (LSE: KNB) recently became the first such to list on the London Stock Exchange’s main market. The Kanabo share price opened to a well-received debut. 

But almost two months later, its share price was down by 40% at the last close. 

Kanabo makes progress

I am not inclined to read much meaning into this, however. There does not seem to be much to explain the drop. In fact, going by the company’s latest update, it is clear that it has in fact made some forward strides. These are aimed at strengthening both production and distribution of its products. 

For production, it has tied up with Poland-based PharmaCann Polska. The company, which has both a cannabis cultivation and extraction facility, will produce Kanabo’s medical formula based on its protocols. It will also supply the cartridges required for its proprietary device VapePod. The device has the advantage of allowing metered doses of medical cannabis.

The company has also signed an agreement with Astral Health for distribution of its medical cannabis formula in the UK. 

Potential for sales expansion

I am particularly looking forward to Kanabo’s progress in the distribution of its products. It has so far run pilots for its products in two of its target markets – the UK and Germany. Its annual revenues are small from these, which I think essentially makes it pre-revenue. 

But, even the data for these years shows progress until 2019. It did slow down in 2020, though, because of the pandemic. As it expands its product distribution further, there should be more sales revenue for Kanabo. I think this can suggest how the company is developing.

Kanabo also has a presence in the wellness segment, which is somewhat separate from medical marijuana. The wellness segment includes products like CBD oils and teas that are available over the counter. 

With retailers now open in the UK again, there could be some pickup in these products too, though they are available online as well. The return of consumers to shops, greater acceptance of cannabis-based products for relaxation and anxiety relief and a likelihood of greater consumer spending post lockdown, could be positive for Kanabo. 

Is the Kanabo share price attractive?

The catch here of course is that it is early days for the company. How the Kanabo share price evolves over time will depend on its progress in growing its market. It will also depend on the regulatory environment, which has not always been positive for similar products. 

All things considered, I am cautiously optimistic on the medical cannabis sector. And going by its growth in markets like the US and Canada, I think this could be the next big thing. I will assess it for a bit longer before taking a plunge, however. Never mind the Kanabo share price fall. 


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

After the FTSE 100 broke 9,000 points, does the UK market look overvalued?

The FTSE 100 went past 9,000 points this week but Mark Hartley says there are still bargains out there and…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Nvidia stock hit an all-time high this week. But could it be a bargain, even now?

After the Nvidia stock hit an all-time high this week, might it still be an attractive opportunity for our writer's…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

As the FTSE 100 hits an all-time high, I’m following Warren Buffett’s advice!

Billionaire investor Warren Buffett is a font of stock market wisdom. Our writer reflects on his approach, as the FTSE…

Read more »

One English pound placed on a graph to represent an economic down turn
Investing Articles

The FTSE 100 reached an all-time high this week. Is it too late to invest?

The FTSE 100 hit a new all-time high level over the past few days. Our writer explains why he thinks…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

Here’s how £9,000 in savings could be used to target £343 a month of passive income

Christopher Ruane sets out a passive income plan that he reckons could help someone make sizeable sums over time without…

Read more »

ISA Individual Savings Account
Investing Articles

How to build a Stocks and Shares ISA with a 6% dividend yield

It’s easy to build an investment portfolio with a high dividend yield today. But investors need to manage risk carefully,…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

How risky is switching from cash savings to a Stocks and Shares ISA?

The UK government is making moves to encourage cash savers to consider investing via Stocks and Shares ISAs. But what…

Read more »

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

4,985 shares of this FTSE dividend star pay an income equal to the State Pension!

Zaven Boyrazian calculates how many shares investors would have to buy to generate enough income to match the UK State…

Read more »